{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:47:25Z","timestamp":1791398845574,"version":"4.3.3"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>\n            Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II\u2013induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12\/group) received angiotensin II (120 ng\/kg per minute, subcutaneously) for 14 days \u00b1 spironolactone or hydralazine (25 mg\/kg per day). An additional group received aldosterone (750 ng\/h, subcutaneously) \u00b1 spironolactone. Systolic blood pressure was increased by angiotensin II (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001) and reduced by spironolactone and hydralazine (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). In mesenteric small arteries studied on a pressurized myograph, media\/lumen ratio was increased (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II\u2013infused rats (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001); both were partially improved by spironolactone (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) but not by hydralazine. Aldosterone-induced increase of media\/lumen ratio (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001) and impaired response to acetylcholine (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid\u2013reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II\u2013induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II\u2013induced vascular effects in hypertension, in part via increased oxidative stress.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000034738.79310.06","type":"journal-article","created":{"date-parts":[[2002,10,3]],"date-time":"2002-10-03T22:24:58Z","timestamp":1033683898000},"page":"504-510","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":347,"title":["Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress"],"prefix":"10.1161","volume":"40","author":[{"given":"Agostino","family":"Virdis","sequence":"first","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Fritsch","family":"Neves","sequence":"additional","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Amiri","sequence":"additional","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Viel","sequence":"additional","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[{"name":"From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1990.70.4.921"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.1.1"},{"key":"e_1_3_3_3_2","first-page":"505","volume":"28","year":"1996","unstructured":"Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension. 1996; 28: 505\u2013506.","journal-title":"Hypertension"},{"key":"e_1_3_3_4_2","unstructured":"L\u00fcscher TF Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton Fla: CRC Press Inc; 1990: 1\u2013215."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.86.5.494"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.10.840"},{"key":"e_1_3_3_7_2","first-page":"98","volume":"1","year":"2000","unstructured":"Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep. 2000; 1: 98\u2013105.","journal-title":"Curr Hypertens Rep"},{"key":"e_1_3_3_8_2","first-page":"639","volume":"52","year":"2000","unstructured":"Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000; 52: 639\u2013672.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.4.1047"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118623"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.99.15.2027"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.50.030188.002205"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1984.246.4.H608"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1139\/y85-250"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.20.1.67"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6363(96)00053-3"},{"key":"e_1_3_3_17_2","first-page":"24316","volume":"289","year":"1994","unstructured":"Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone: biosynthesis and a link to angiotensin II\u2013induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994; 289: 24316\u201324320.","journal-title":"J Biol Chem"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.9.1821"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.451"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.2.787"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.14.1653"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.21.4.391"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.3.606"},{"key":"e_1_3_3_24_2","first-page":"219","volume":"8","year":"2001","unstructured":"Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, Armstrong D, Reiser B, Trevisan M. TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk. 2001; 8: 219\u2013225.","journal-title":"J Cardiovasc Risk"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.5.6_pt_3.v16"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.3.581"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.2.574"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.4.617"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.5.626"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.6.1331"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.32.3.452"},{"key":"e_1_3_3_32_2","first-page":"2797","volume":"81","year":"1996","unstructured":"Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabushi H, Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1996; 81: 2797\u20132800.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.28.5.785"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.6.1444"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.6.594"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.499"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.21.6.929"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.80.1.45"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118935"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200202000-00005"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000034738.79310.06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:18:02Z","timestamp":1715530682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000034738.79310.06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1161\/01.HYP.0000034738.79310.06"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000034738.79310.06","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"2002-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-09-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}